[1] Zitzmann S, Ehemann V, Schwab M. Arginine-glycineaspartic acid (RGD)-peptide binds to both tumor and tumorendothelial

cells in vivo [J]. Cancer Res, 2002, 62(18): 5139-5143.

[2] Liu Y, Lu W. Recent advances in brain tumor-targeted nanodrug delivery systems [J]. Expert Opin Drug Deliv, 2012, 9(6): 671-686.

[3] Zhan C, Lu W. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery [J]. Curr Pharm Biotechnol, 2012, 13(12): 2380-2387.

[4] Nabors LB, Mikkelsen T, Rosenfeld SS, et al. Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma [J]. J Clin Oncol, 2007, 25(13): 1651-1657.

[5] Reardon D, Fink K, Nabors B, et al. Phase IIa trial of cilengitide (EMD121974) single-agent therapy in patients (pts) with recurrent glioblastoma (GBM): EMD 121974-009 [J]. J Clin Oncol, 2007, 25(18 Suppl): 2002-2012.

[6] Friess H, Langrehr JM, Oettle H, et al. A randomized multicenter phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer [J]. BMC Cancer, 2006, 6(1): 285-296.

[7] Curnis F, Gasparri A, Sacchi A, et al. Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity [J]. Cancer Res, 2004, 64(2): 565-571.

[8] Suh W, Han SO, Yu L, et al. An angiogenic, endothelial-celltargeted polymeric gene carrier [J]. Mol Ther, 2002, 6(5): 664-672.

[9] Miller CR, Buchsbaum DJ, Reynolds PN, et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer [J]. Cancer Res, 1998, 58(24): 5738-5748.

[10] Reynolds P, Dmitriev I, Curiel D. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector [J]. Gene Ther, 1999, 6(7): 1336-1339.

[11] Fueyo J, Alemany R, Gomez-Manzano C, et al. Preclinical characterization of the antiglioma activity of a tropismenhanced adenovirus targeted to the retinoblastoma pathway [J]. J Natl Cancer Inst, 2003, 95(9): 652-660.

[12] Yong RL, Shinojima N, Fueyo J, et al. Human bone marrowderived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas [J]. Cancer Res, 2009, 69(23): 8932-8940.

[13] Zhang L, Zhu S, Qian L, et al. RGD-modified PEGPAMAM-DOX conjugates: in vitro and in vivo studies for glioma [J]. Eur J Pharm Biopharm, 2011, 79(2): 232-240.

[14] Waite CL, Roth CM. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma [J] . Bioconjug Chem, 2009, 20(10) : 1908-1916.

[15] Liu X, Cui W, Li B, et al. Targeted therapy for glioma using cyclic RGD-entrapped polyionic complex nanomicelles [J]. Int J Nanomedicine, 2012, 7: 2853-2862.

[16] Chen Z, Deng J, Zhao Y, et al. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats [J]. Int J Nanomedicine, 2012, 7: 3803-3811.

[17] Liu Z, Shi J, Jia B, et al. Two 90Y-labeled multimeric RGD peptides RGD4 and 3PRGD2 for integrin targeted radionuclide therapy [J]. Mol Pharm, 2011, 8(2): 591-599.

[18] Gross S, Piwnica-Worms D. Spying on cancer: molecular imaging in vivo with genetically encoded reporters [J]. Cancer Cell, 2005, 7(1): 5-15.

[19] Chen X, Park R, Shahinian AH, et al. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis [J]. Nucl Med Biol, 2004, 31(2): 179-189.

[20] Chen X, Park R, Hou Y, et al. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide [J]. Eur J Nucl Med Mol Imaging, 2004, 31(8): 1081-1089.

[21] Wu Z, Li ZB, Cai W, et al. 18F-labeled mini-PEG spacered RGD dimer ( 18F-FPRGD2) : synthesis and microPET imaging of αvβ3 integrin expression [J]. Eur J Nucl Med Mol Imaging, 2007, 34(11): 1823-1831.

[22] Schnell O, Krebs B, Carlsen J, et al. Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography [J]. Neuro Oncol, 2009, 11(6): 861-870.

[23] Wu Z, Li ZB, Chen K, et al. MicroPET of tumor integrin αvβ3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) [J]. J Nucl Med, 2007, 48(9): 1536-1544.

[24] Wu Y, Zhang X, Xiong Z, et al. MicroPET imaging of glioma integrin αvβ3 expression using 64Cu-labeled tetrameric RGD peptide [J]. J Nucl Med, 2005, 46(10): 1707-1718.

[25] Li ZB, Cai W, Cao Q, et al. 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor αvβ3 integrin expression [J]. J Nucl Med, 2007, 48(7): 1162-1171.

[26] Shi J, Kim YS, Zhai S, et al. Improving tumor uptake and pharmacokinetics of 64Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers [J]. Bioconjug Chem, 2009, 20(4): 750-759.

[27] Liu Z, Cai W, He L, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice [J]. Nat Nanotechnol, 2006, 2(1): 47-52.

[28] Li ZB, Chen K, Chen X. 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression [J]. Eur J Nucl Med Mol Imaging, 2008, 35(6): 1100-1108.

[29] Morales-Avila E, Ferro-Flores G, Ocampo-García BE, et al. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C) ] for molecular imaging of tumor αvβ3 expression [J]. Bioconjug Chem, 2011, 22(5): 913-922.

[30] Chen X, Conti PS, Moats RA. In vivo near-infrared fluorescence imaging of integrin αvβ3 in brain tumor xenografts [J]. Cancer Res, 2004, 64(21): 8009-8014.

[31] Hsu AR, Hou LC, Veeravagu A, et al. In vivo near-infrared fluorescence imaging of integrin αvβ3 in an orthotopic glioblastoma model [J]. Mol Imaging Biol, 2006, 8(6): 315-323.

[32] Wu Y, Cai W, Chen X. Near-infrared fluorescence imaging of tumor integrin αvβ3 expression with Cy7-labeled RGD multimers [J]. Mol Imaging Biol, 2006, 8(4): 226-236.

[33] Cai W, Shin DW, Chen K, et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects [J]. Nano Lett, 2006, 6(4): 669-676.

[34] Cai W, Chen K, Li ZB, et al. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature [J]. J Nucl Med, 2007, 48(11): 1862-1870.